BA
SRTS icon

Bard Associates’s Sensus Healthcare SRTS Stock Holding History

Bard Associates’s Portfolio SRTS Stock Details SRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-12,000
Closed -$60K – 178
2017
Q3 		$60K Sell
12,000
-64,600
-84% -$317K 0.03% 169
2017
Q2 		$308K Hold
76,600
– – 0.14% 135
2017
Q1 		$336K Sell
76,600
-2,400
-3% -$11.3K 0.16% 128
2016
Q4 		$415K Sell
79,000
-1,000
-1% -$5.84K 0.19% 118
2016
Q3 		$492K Buy
+80,000
New +$501K 0.24% 109

Other funds holding SRTS

AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
GBA
Garrison Bradford & Associates New York $92.2M AUM 19.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bard Associates's SRTS Position: Q4 2017 in Review

Bard Associates sold out of Sensus Healthcare (SRTS) in Q4 2017, closing a stake of 12,000 shares — an estimated $60K sold.

Bard Associates first reported a position in SRTS in Q3 2016 and held it in 5 quarters. The position peaked at $492K in Q3 2016. 11 funds tracked by Wall St. Rank hold SRTS as of Q4 2017.

  • Bard Associates reported no remaining Sensus Healthcare position as of Q4 2017 after selling out during the quarter.
  • Bard Associates sold 12,000 Sensus Healthcare shares in Q4 2017, an estimated $60K.
  • Bard Associates first reported a position in Sensus Healthcare in Q3 2016 and held it in 5 quarters.
  • Bard Associates's Sensus Healthcare position peaked at $492K in Q3 2016.
  • 11 funds tracked by Wall St. Rank held Sensus Healthcare as of Q4 2017.

Based on Bard Associates's 13F filing for Q4 2017, filed 13 Feb 2018.